Evaluation of the Antitumor Activity of Dacomitinib in Models of Human Bladder Cancer
Abstract Members of the human epidermal growth factor receptor (HER) family play a significant role in bladder cancer progression and may underlie the development of chemotherapy resistance. Dacomitinib is an irreversible tyrosine kinase inhibitor with structural specificity for the catalytic domain...
| Κύριοι συγγραφείς: | , , , , , , , , , , |
|---|---|
| Μορφή: | Άρθρο |
| Γλώσσα: | English |
| Έκδοση: |
BMC
2013-10-01
|
| Σειρά: | Molecular Medicine |
| Θέματα: | |
| Διαθέσιμο Online: | https://doi.org/10.2119/molmed.2013.00108 |